Insulin and reconciliation

With Congress sending to the president a partisan reconciliation spending bill, the cost of insulin is receiving greater attention. Numerous proposals have been introduced in recent months aimed at capping what patients pay out of pocket for insulin. Despite what theWhite House ’s talking points falsely suggest, PhRMA hasn ’t taken a position on these bills. The same can’t be said, however, of pharmacy benefit managers – middlemen who work for insurers. Their association has been running ads urging lawmakers to reject lower insulin costs for patients:
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Diabetes Health Insurance Pharmacy Benefit Managers Source Type: news